
Cocrystal Pharma Inc (COCP)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -42.894 | -0.498 | -51.633 | -99.222 | -23.312 | -21.23 | -64.603 | -49.887 |
Return on Equity (%) | -55.48 | -0.59 | -56.937 | -104.041 | -24.671 | -21.814 | -66.322 | -54.537 |
Return on Invested Capital (%) | -78.832 | -7.121 | -72.525 | -4.972 | -24.528 | -21.878 | -33.73 | -56.36 |
Operating Margin (%) | N/A | N/A | N/A | -733.547 | -478.649 | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | -733.836 | -479.047 | N/A | N/A | N/A |
Book Value Per Share | -0.024 | -0.564 | 0.057 | 0.188 | 0.474 | 0.6 | 4.859 | 2.593 |
Earnings Per Share | -0.105 | -0.025 | -1.638 | -1.37 | -0.137 | -0.146 | -4.769 | -1.768 |
Cash Per Share | 0.005 | 0.031 | 0.091 | 0.211 | 0.469 | 0.602 | 4.561 | 2.59 |
Working Capital Per Share | 0.005 | 0.032 | 0.046 | 0.171 | 0.464 | 0.593 | 4.785 | 2.539 |
Operating Profit Per Share | N/A | N/A | N/A | 0.187 | 0.029 | N/A | N/A | 0.256 |
EBIT Per Share | -0.146 | -0.309 | -2.092 | -1.37 | -0.137 | -0.146 | -4.769 | -1.768 |
EBITDA Per Share | -0.146 | -0.309 | -2.092 | -1.37 | -0.137 | -0.146 | -4.769 | -1.768 |
Free Cash Flow Per Share | -0.105 | -0.028 | -1.639 | -1.369 | -0.136 | -0.147 | -4.783 | -1.775 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 714,03M | 24,28M | 29,94M | 35,15M | 70,44M | 97,47M | 8,14M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 8,14M | N/A | 10,17M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 13,33M |
Ratio cours/bénéfice | -0,74 |
Ratio prix/ventes | 5,13 |
Ratio prix/liquidités | 0,51 |
Ratio prix/valeur comptable | 0,51 |
Rendement de dividende | - |
Actions en circulation | 10,17M |
Volume moyen (1 semaine) | 10,15k |
Volume moyen (1 mois) | 16,81k |
Variation sur 52 semaines | -7,69% |
Plus haut sur 52 semaines | 3,26 |
Plus bas sur 52 semaines | 1,10 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales